Cargando…

Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.

Detalles Bibliográficos
Autores principales:	Joseph, R. R., Belpomme, D., Mathé, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1976
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024950/ https://www.ncbi.nlm.nih.gov/pubmed/776199

Ejemplares similares

Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
por: Harris, R., et al.
Publicado: (1978)

Long‐term remission of extramedullary cutaneous relapse of acute myeloid leukaemia (leukaemia cutis) treated with decitabine‐venetoclax
por: Maravalle, Denise, et al.
Publicado: (2022)

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
por: Freeman, Ciara L., et al.
Publicado: (2016)

Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.
por: Summerfield, G. P., et al.
Publicado: (1979)

Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)

Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
por: Cocks, P., et al.
Publicado: (1977)

Immunotherapy in leukaemia: Immunotherapy in leukaemia
por: Mu, Xingmei, et al.
Publicado: (2023)

Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975)

Seasonality in the diagnosis of acute lymphocytic leukaemia.
por: Badrinath, P., et al.
Publicado: (1997)

Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia
por: Harrop, Sean, et al.
Publicado: (2023)

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.
por: Mathé, G., et al.
Publicado: (1969)

Null-cell properties of a lymphoid cell line from a child with acute lymphoblastic leukaemia.
por: Karpas, A., et al.
Publicado: (1977)

Increased potassium in lymphocytes from patients with chronic lymphatic leukaemia.
por: Flahavan, E., et al.
Publicado: (1973)

Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia
por: Pal, D, et al.
Publicado: (2016)

A Case of Acute Leukaemia with Complete Remission and Death from Subsequent Development of Chloromata
por: Anderson, C. D., et al.
Publicado: (1954)

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia
por: Nilsson, Malin S., et al.
Publicado: (2019)

Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
por: Zuhrie, S. R., et al.
Publicado: (1980)

A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia.
por: Palmer, M. K., et al.
Publicado: (1980)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission.
por: Pizzolo, G., et al.
Publicado: (1988)

Childhood leukaemia in The Netherlands, 1973-1986: temporary variation of the incidence of acute lymphocytic leukaemia in young children.
por: Coebergh, J. W., et al.
Publicado: (1989)

Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.
por: Taylor, G. M., et al.
Publicado: (1984)

Immunotherapy of acute myeloid leukaemia. Medical Research Council.
Publicado: (1978)

Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.
por: Taylor, G. M., et al.
Publicado: (1976)

Proceedings: Triple chemotherapy in acute non-lymphocytic leukaemia.
por: Fennelly, J. J., et al.
Publicado: (1974)

An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia.
por: Bosanquet, A. G., et al.
Publicado: (1983)

Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity.
por: Gale, D. G., et al.
Publicado: (1977)

Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy.
por: Taylor, G. M., et al.
Publicado: (1975)

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
por: Casirati, Gabriele, et al.
Publicado: (2023)

Prospects for achieving treatment‐free remission in chronic myeloid leukaemia
por: Saglio, Giuseppe, et al.
Publicado: (2020)

Ribosomal RNA Synthesis in Chronic Lymphocytic Leukaemia
por: Billington, R. W., et al.
Publicado: (1974)

Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine
por: Hwang, Yu-Yan, et al.
Publicado: (2012)

Divergent Autologous T Cell Responses to Leukaemic Dendritic Cells during Remission in Acute Promyelocytic Leukaemia
por: Westers, Theresia M., et al.
Publicado: (2005)

Complete remission of IgA nephropathy after bone marrow transplantation for acute myeloid leukaemia
por: Park, Eun-Kyung, et al.
Publicado: (2008)

Magnetic field exposure and long-term survival among children with leukaemia
por: Foliart, D E, et al.
Publicado: (2006)

Magnetic field exposure and long-term survival among children with leukaemia
por: Foliart, D E, et al.
Publicado: (2006)

Remission and long-term remission of pediatric-onset systemic lupus erythematosus
por: Chen, Yi-Chieh, et al.
Publicado: (2023)

A Case of Lymphocytic Leukæmia
por: Reynolds, Fredrick H.
Publicado: (1933)

Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
por: Taylor, G. M., et al.
Publicado: (1976)

Adult Acute Leukaemia
por: Atkinson, K., et al.
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_vqksr3o3081cbmnbrrkbhkmggf